Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.66 USD | +6.65% | +11.14% | +72.90% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.90% | 5.62B | |
+4.95% | 109B | |
+10.94% | 105B | |
-0.38% | 22.25B | |
-12.37% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.55% | 16.85B | |
+4.48% | 13.76B | |
+34.82% | 12.46B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Transcript : ImmunityBio, Inc. - Special Call